|
|
|
|
Vol. 11, Issue 5, 1919-1932, May 2000



*Weston Laboratory, Division of Paediatrics, Obstetrics, and
Gynaecology, and
Division of Investigative Sciences,
Imperial College of Science, Technology, and Medicine, Hammersmith
Hospital, London W12 0NN, United Kingdom;
Unité de
Recherches sur les Handicaps Génétiques de l'Enfant,
Institut National de la Santé et de la Recherche Médicale
U393, Hôpital Necker Enfants Malades, 75743 Paris Cedex 15, France; and
Department of Neurochemistry, Institute of
Neurology, University College London, London WC1N 1PJ, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
Maple syrup urine disease (MSUD) is an inborn error of
metabolism caused by a deficiency in branched chain
-keto
acid dehydrogenase that can result in neurodegenerative sequelae in
human infants. In the present study, increased concentrations of MSUD
metabolites, in particular
-keto isocaproic acid, specifically
induced apoptosis in glial and neuronal cells in culture. Apoptosis was
associated with a reduction in cell respiration but without impairment
of respiratory chain function, without early changes in mitochondrial membrane potential and without cytochrome c release into
the cytosol. Significantly,
-keto isocaproic acid also
triggered neuronal apoptosis in vivo after intracerebral injection into
the developing rat brain. These findings suggest that MSUD
neurodegeneration may result, at least in part, from an accumulation of
branched chain amino acids and their
-keto acid derivatives that
trigger apoptosis through a cytochrome c-independent pathway.
| |
INTRODUCTION |
|---|
|
|
|---|
Maple syrup urine disease (MSUD) is an inborn error of metabolism
caused by a deficiency in branched chain
-keto acid dehydrogenase, leading to the accumulation of branched chain amino acids (BCAAs; leucine, valine, and isoleucine) and a corresponding increase in their
-keto acid derivatives (BCKA;
-keto isocaproic acid [KICA],
-keto valeric acid, and
-keto-
-methyl-n-valeric
acid [KILE]) levels (Snyderman, 1988
). Acute neurological
deterioration in children is often associated with increased plasma and
cerebrospinal fluid concentrations of BCAA and BCKA (Riviello et
al., 1991
; Levin et al., 1993
). Magnetic resonance
imaging studies in children with MSUD have confirmed both white matter
and neuronal injury, including extensive brain edema and pathological
changes in the basal ganglia (Brismar et al., 1990
; Steinlin
et al., 1998
). At the histopathological level, deficiencies
in myelination of major tracts in the pons and spinal cord, widespread
areas of spongy change in the white matter, focal areas of
astrocytosis, and binucleated neurons have also been reported
(Langenbeck, 1984
). Because concentrations of BCAA are increased in the
cerebrospinal fluid, we hypothesized that pathological changes
in the central nervous system may reflect a neurotoxic effect of BCAAs
and their keto acids.
Although the underlying mechanisms of cellular toxicity are not known,
there is direct evidence that BCKAs affect mitochondrial enzymes,
resulting in impaired energy metabolism (Dreyfus, and Prensky, 1967
;
Walajtys-Rode and Williamson, 1980
; Jackson and Singer, 1983
; Zielke
et al., 1997
). Because reduced mitochondrial function can
trigger apoptosis, we set out to address the following questions: 1)
can BCAAs or BCKAs induce apoptosis in neural cells in vitro and in
vivo; and 2) is mitochondrial impairment involved in this toxic effect?
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials
Glucose-rich (4.5 g/l) Dulbecco's modified Eagle's medium
(DMEM), leucine, valine, isoleucine, KICA,
-keto valeric acid, KILE,
3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide (MTT),
staurosporine (SSP), and cycloheximide were obtained from Sigma (Poole,
United Kingdom). Fetal calf serum (FCS) and tissue culture plastics
were obtained from Life Technologies (Paisley, United Kingdom).
Eight-well chamber slides were obtained from Nunc Laboratories
(Naperville, IL). The mitochondrial membrane potential indicators
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzinamidazol carbocyanine
iodide (JC-1), rhodamine-123 (Rh-123), and tetramethylrhodamine ethyl ester (TMRE) were purchased from Molecular Probes (Eugene, OR).
The cell-permeable caspase inhibitors Boc-Asp-fluoromethylketone (BAF),
Z-Asp-Glu-Val-Asp-fluoromethylketone (DEVD-FMK), and
Ac-Ile-Glu-Thr-Asp-fluoromethylketone (IETD-FMK) were purchased from
Enzyme Systems Products (Livermore, CA).
Cell Culture
Cell Lines. B104 (rat neuroblastoma), N1E-115 (mouse neuroblastoma/rat glioma hybrid), and C6 (rat glioma) cells were cultured in 10-cm tissue culture dishes, in DMEM containing 10% FCS, supplemented with penicillin and streptomycin. Cells were seeded at 2 × 105 per dish, subcultured twice weekly, and incubated at 37°C in a humidified atmosphere of 10% CO2 and 90% air. Individual cultures were maintained for no more than 6 wk.
Culture and Assay of Cerebellar Granular Neurons.
Cerebellar
granule cultures were prepared from the cerebella of 7-d-old rat pups
as described previously (Pocock et al., 1993
). Cells were
plated on poly-D-lysine-coated coverslips at a
density of 2.5 × 105 per coverslip and
maintained in minimum essential medium with Earle's salts supplemented
with 25 mM KCl, 30 mM glucose, 25 mM NaHCO3,
1 mM glutamine, and 10% FCS, incubated at 37°C
in a humidified atmosphere of 5% CO2 and 95%
air, and used within 8 d.
Preparation of Primary Oligodendrocytes and Astrocytes.
Glial cultures were prepared from newborn Wistar rat brains (Collarini
et al., 1992
) and enriched for oligodendrocytes and astrocytes by sequential immunopanning (Barres et al., 1992
)
as described previously.
Survival Assay by the Tetrazolium Salt Method (MTT assay)
The tetrazolium salt assay relies on the conversion of MTT to
colored formazan by succinate dehydrogenase in metabolically active
cells and provides a measurement of cell viability. For viability
experiments, 100-µl aliquots of DMEM/0.5% FCS containing 104 cells (for cell lines) or 50-µl aliquots of
Sato's medium containing 5 × 103 primary
astrocytes or oligodendrocytes were placed into 96-well tissue culture
plates and treated with defined concentrations of BCAA, BCKA, SSP, or
cycloheximide. At the end of the experiment, cell viability was
measured by MTT assay as previously described (Hansen et
al., 1989
). Results are expressed as percent viability according
to the equation:
|
-keto isocaproic acid (KICA) or SSP.
Electron Microscopy
C6 cells (105/ml) were cultured in 24-well plates (0.5 ml/well) on sterile coverslips. At the start of the experiment, cells were treated with 600 µl of medium containing 0.5% FCS alone or defined concentrations of BCAA, BCKA, SSP, or cycloheximide. After incubation for 20 h at 37°C, cultures were washed twice in PBS, fixed in 2% glutaraldehyde for 2 h at 4°C, washed, osmicated, and dehydrated before embedding in Taab resin. Coverslips were snapped off with liquid nitrogen, and 1-µm sections were cut and stained with toluidine blue for block selection at the light microscope level. Sections of 100 nm thickness were then cut and collected on nickel grids, stained with uranyl acetate and lead citrate, and examined by electron microscopy (CM-10; Philips, Eindhoven, The Netherlands).
In Situ End Labeling (ISEL)
C6 cells were cultured in eight-well chamber slides at a density
of 105/ml (300 µl/well) in DMEM containing
0.5% FCS alone or in the presence of defined concentrations of BCAA,
BCKA, SSP, or cycloheximide. After a 20-h incubation at 37°C, ISEL
was performed as described previously (Ansari et al., 1993
)
with minor modifications (Joashi et al., 1999
).
DNA Laddering
One of the hallmarks of apoptosis is the endonuclease-mediated
degradation of chromatin, giving rise to characteristic DNA laddering
(Wyllie et al., 1992
). To investigate apoptotic DNA fragmentation, C6 cells were cultured on 5-cm dishes at a density of
4 × 106 cells per dish (5 ml). At the start
of the experiment, cultures were washed and treated with 2 ml of DMEM
containing 0.5% FCS alone or in the presence of BCAA, BCKA, or SSP for
defined times at 37°C. DNA from treated cultures was isolated (Laird
et al., 1991
) and assayed for oligonucleosomal laddering
(Khan et al., 1997
) as described previously.
Western Blotting
To measure caspase-dependent cleavage of
poly(ADP-ribose)polymerase (PARP), C6 cells were cultured on six-well
plates at a density of 106 cells/ml (2.5 ml/well). After 12 h, cultures were washed and treated with 500 µl of DMEM containing 0.5% FCS alone or defined concentrations of
BCAA, BCKA, or SSP. At defined times, total cells from each well were
lysed in 1% SDS (500 µl/well) and heated for 5 min at 90°C.
Protein concentrations were determined by the bicinochinic acid method
using a commercial kit from Pierce (Chester, United Kingdom), and
lysates were stored at
80°C before use.
Total cellular proteins (50 µg/lane) were separated on a 7.5% polyacrylamide gel and electrotransferred onto nitrocellulose membranes (Hybond ECL; Amersham, Little Chalfont, United Kingdom). Primary incubations were with mouse monoclonal anti-PARP antibody C-2-10 (Transduction Laboratories, Lexington, KY) diluted 1:3000 for 1 h at room temperature. Secondary incubations were with horseradish peroxidase-conjugated anti-mouse antibody (Amersham) diluted 1:1000 under the same conditions. Bound antibodies were visualized with enhanced chemiluminescence reagent (Supersignal horseradish peroxidase; Pierce), and serial exposures were made to radiographic film (Hyperfilm ECL; Amersham). The resulting blots were scanned by densitometry for band quantitation.
Caspase Activity Assays
C6 cells (1 × 106 per well) were
grown on six-well plates. At the start of the experiment, cultures were
washed and treated with 0.5 ml of DMEM containing 10% conditioned
medium alone or in the presence of KICA or SSP for 3 h at 37°C.
Monolayers were then washed twice in PBS and lysed in a buffer
containing 50 mM HEPES, pH 7.4, 0.1 mM EDTA, 1 mM DTT, and 0.1%
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (50 µl/well). The lysates were freeze fractured three times (
80°C, 10 min) and clarified by centrifugation (5 min, 10,000 × g). Supernatants were used for enzyme assays using the
caspase 3 substrate (Z-Asp-Glu-Val-Asp-pNA) purchased from Biomol
(Plymouth Meeting, PA). The caspase assay was carried out according to
the protocol provided by the manufacturer, and absorbance was measured at 405 nm in a spectrophotometer plate reader.
Studies of Cell Respiration
Cellular oxygen consumption was measured polarographically in
both intact and digitonin-permeabilized C6 cells. At the start of the
experiment, C6 cells cultured on 10-cm dishes (3 × 106 cells per dish) were washed and treated with
DMEM containing 0.5% FCS alone or in the presence of defined MSUD
metabolites or SSP (1 µM). After 4 h, cell suspensions were
prepared from treated monolayers, and measurements of respiration were
performed on intact cells as described previously (Rustin et
al., 1994
). In addition, the succinate oxidation rate was assayed
in parallel cultures permeabilized with digitonin (0.002%, wt/vol),
with successive additions of rotenone (3 µM), succinate (10 mM), ATP
(0.2 mM), and cytochrome c (20 µM) as described (Rustin
et al., 1994
). Protein content was estimated according to
the method of Bradford (1976)
, and the results were normalized accordingly.
Cytochrome c Release
The release of cytochrome c from the mitochondria to
the cytosol was investigated by Western blotting of fractionated cells. C6 cells were cultured on 10-cm dishes, washed, and incubated for
defined times at 37°C in DMEM containing 0.5% FCS alone or in the
presence of KICA or SSP. At the end of the experiment, mitochondrial
and cytosolic fractions were prepared as described previously (Rickwood
et al., 1987
) and assayed (25 µg/lane) by Western blotting
as described above. The primary antibodies used were 1) a mouse
monoclonal antibody raised against cytochrome c (PharMingen,
San Diego, CA) used at a dilution of 1:500 and 2) a mouse monoclonal
antibody raised against subunit IV of cytochrome oxidase (Molecular
Probes) used at a dilution of 1:500.
Determination of Mitochondrial Membrane Potential
Changes in mitochondrial membrane potential
(
m) were measured at both the population
and single-cell levels.
Determination of 
m in Cultures of C6
Cells.
To measure 
m changes in whole
cultures of C6 cells treated with KICA, the carbocyanine dye JC-1 was
used as a mitochondrial membrane potential indicator probe. When
excited at 490 nm, JC-1 is able to selectively enter the mitochondria
and form aggregates that emit at 585 nm (orange-red). If the

m is reduced, JC-1 disaggregates to
monomers that emit fluorescence at 527 nm (green). Thus, the color of
the dye changes reversibly from orange to green as the membrane
depolarizes (Reers et al., 1991
; Smiley et al., 1991
; Salvioli et al., 1997
).

m,
drugs were removed at the times stated by gently washing the cells in
DMEM. Next, 50 µl of treatment solution containing 6 µM JC-1 (made
from a frozen stock solution of 10 mM JC-1 in dimethylfluoride) in
serum-free DMEM were added to each well, and cultures were incubated
for a further 20 min at 37°C. Subsequently the cell monolayers were
washed in PBS, and the fluorescence was measured using a Cytofluor 2300 plate reader (Millipore, Watford, United Kingdom; excitation
, 485 nm; emission
, 530 and 590 nm). The results are expressed as the
ratio of JC-1 monomers against aggregates to reflect changes in

m.
Single-Cell Fluorescence Imaging.
C6 cells or primary
cerebellar granule neurons were cultured as described above and plated
in 24-well plates on circular glass coverslips at a density of
105 cells/ml (0.5 ml/well). Cells were preloaded
with single dyes by incubation in 6 µM JC-1 (20 min), 200 nM TMRE (90 min), or 1.3 µM Rh-123 (15 min) at 5% CO2/air
and 37°C. The cells were briefly washed, and 250 µl of phenol
red-free MEM, supplemented with HEPES and glucose (Sigma) were added to
each well. Individual coverslips were placed in the thermostated holder
(set to 37°C) of an Olympus IX70 inverted fluorescence microscope. At
defined time points KICA (50 mM) or FCCP (50 µM) was gently added
directly to the chamber. Images were captured using a diachroic mirror with excitation
and emission
, respectively, at 490 and 590 nm
(JC-1), 520 and 550 nm (TMRE), and 485 and 520 nm (Rh-123) using a
SpectraMASTER monochromator (Life Science Resources, Cambridge, United Kingdom). For JC-1 experiments, an Omega Optical XF32 590-nm emission filter (OF35; Molecular Probes) was fitted to visualize only
the red signal from JC-1 aggregates and to prevent contamination of the
emission signal with green fluorescence from disaggregated JC-1
monomers. Images were acquired using an AstroCam 12-bit digital camera,
and the output was visualized with a Merlin imaging system, version
1.85 (both from Life Science Resources).
In Vivo Studies of KICA Neurotoxicity
Animal Preparation and Intracerebral Injection. All animal procedures used were in accordance with the United Kingdom Home Office guidelines and specifically licensed under the Animals (Scientific Procedures) Act, 1986. Anesthesia in 14-d Wistar rats was induced and maintained with halothane (5 and 1-2%, respectively) in oxygen:air (1:1). The skull was exposed, and the interaural line was visualized. A 23-gauge needle with syringe was stereotactically inserted through a small burr hole into the right forebrain (2.6 mm anterior to the interaural line, 1.5 mm laterally, 3.0 mm deep). Animals received a single 2-µl bolus of 0.9% saline alone or containing KICA (50, 100, and 200 mM; all adjusted for isotonicity and pH 7.4) injected over 2 min. Two animals were used at each time point and for each KICA concentration studied, with two animals receiving saline. After wound closure, animals were returned to their dam.
Histology and ISEL.
At 24 h and 5 d after
injection, animals were killed (by intraperitoneal injection of
pentobarbitone, 30 mg/kg) and transcardially perfused with 25-30 ml of
0.9% NaCl followed by 25-30 ml of PFA (4%, wt/vol, in 0.9% NaCl).
Brains were then removed, fixed overnight in 4% PFA at 4°C, rinsed
in PBS, and then transferred to 15% (wt/vol) sucrose in PBS (4°C).
Specimens were routinely dehydrated in serial alcohols and paraffin
embedded before sectioning. Coronal sections (5 µm) were cut at a
point corresponding to between 2.4 and 2.8 mm anterior to the
interaural line (Sherwood and Timiras, 1970
).
| |
RESULTS |
|---|
|
|
|---|
MSUD Metabolites Are Toxic to Cultured Glial and Neuronal Cells
Because MSUD results in an accumulation of BCAAs and their keto
acid derivatives, we first investigated the effect of the MSUD
metabolite KICA on cell viability in selected glial and neuronal lines
by MTT assay. KICA induced cell death in all these lines in a
dose-dependent manner (Figure 1A). At the
highest dose tested (50 mM KICA), viability in C6, B104, and N1E-115
cells was reduced to 34, 44, and 46%, respectively. Because C6
(astroglial) cells were the most sensitive, and because MSUD is
primarily a white matter disease, this line was selected for further
investigation.
|
We next compared the effect of BCAAs with their keto acid
derivatives (Figure 1B). In every case the
-keto acid was more toxic
than its parent BCAA. For example, in C6 cultures treated with 25 mM
isoleucine or its analogue KILE alone, the maximum amount of cell death
observed was 7 and 55%, respectively. KICA is the most abundant BCKA
in MSUD patients and was therefore selected for further investigation.
Leucine and KICA Act Synergistically to Induce Cell Death
In MSUD, both BCAAs and their respective
-keto acids
accumulate. Thus, we next investigated the effects of combined
treatment of C6 cells with leucine and its keto derivative KICA. As
shown in Figure 1C, leucine was not significantly toxic up to a
concentration of 10 mM, whereas at the same concentration, KICA
resulted in 27% cell death. The combination of 10 mM leucine and 10 mM
KICA significantly reduced cell viability to 41%.
The Mechanism of Cell Death Induced by MSUD Metabolites Is Apoptosis
Morphological analysis at the subcellular level remains the most conclusive method for distinguishing apoptosis from necrosis. Hematoxylin and eosin staining revealed that cultures underwent a marked change in morphology after treatment with BCKAs. Although control cultures of C6 cells had distinct processes and large, rounded nuclei, KICA-treated cells were smaller, displaying reduced cytoplasmic volume and marked nuclear pyknosis; moreover, these shrunken (and sometimes fragmented) nuclei were significantly more basophilic than their healthy counterparts (our unpublished results).
Induction of apoptosis by KICA was confirmed by electron microscopy
(Figure 2). Healthy cultures of C6 cells
were spindle shaped with large, oval, euchromatic nuclei. Cytoplasm
contained dark, somewhat elongated mitochondria and considerable
quantities of intermediate filaments (possibly glial fibrillary acidic
protein), characteristically arranged in bundles parallel to the plasma membrane. In contrast, KICA-treated cells demonstrated typical apoptotic morphology; the cells were rounded, containing condensed nuclei with chromatin crescents. Cytoplasm was shrunken and electron dense with prominently dilated endoplasmic reticulum, frequently seen
to open onto the cell surface, a feature consistent with cell shrinkage
caused by the expulsion of water. Organelles, including mitochondria,
were tightly packed into the remaining cytosol (Figure 2A). In some
cells characteristic cytoplasmic blebbing could be seen, leading to the
formation of numerous apoptotic bodies from a single cell (Figure 2B).
Changes in mitochondrial morphology, in particular reduction in
mitochondrial volume, close intermitochondrial juxtaposition, and
retention of seemingly functional intact double membrane structure,
were also consistent with cell death by apoptosis.
|
Molecular Evidence for Apoptosis: Caspase Activation
Biochemical markers for caspase activation and endonuclease
activation after treatment with BCKA provided further evidence that the
mode of cell death was apoptosis. Caspase activation was first
investigated by measuring cleavage of PARP (a known substrate) to an
Mr 85,000 fragment.
Immunoblotting analysis revealed that healthy C6 cells
predominantly expressed the intact Mr
116,000 PARP protein, with only a minor band (14% of the total PARP
protein) at Mr 85,000, representing
the caspase-3-cleaved product. After treatment with KICA or the protein
kinase inhibitor SSP for 1 h, PARP cleavage increased
significantly. This effect was time dependent, with maximum cleavage
(45%) occurring at 3 h after treatment with KICA (Figure
3A). In addition to intact PARP and the
Mr 85,000 cleavage product,
immunoblotting with the PARP antibody revealed a third
protein with an apparent molecular mass of 104,000 that was detected in
both control and treated cultures and did not increase significantly
after treatment with KICA.
|
Caspase activity was also measured directly, using the caspase-3 substrate DEVD-pNA. After 3 h of KICA treatment, caspase activity increased in C6 cells by 220%. Although this was a significant increase over control levels, it represented only 30% of DEVD-specific caspase activation in response to SSP, which was almost eightfold higher than untreated cultures (Figure 3B). We next investigated the role of caspase activation in the toxic effects of KICA. Cells exposed to KICA or SSP were simultaneously treated with cell-permeable caspase inhibitors. Three separate inhibitors were used: the ubiquitous caspase inhibitor BAF, the preferred caspase-3 substrate DEVD-FMK, and the caspase-8 substrate IETD-FMK. As shown in Figure 3C, in cells treated with KICA or SSP alone, MTT metabolism was reduced by 55 and 67%, respectively. This reduction in MTT metabolism was significantly blocked by the presence of BAF but not by DEVD-FMK or IETD-FMK (Figure 3C).
Molecular Evidence for Apoptosis: DNA Fragmentation
Further molecular evidence of apoptosis after treatment
with BCKAs was obtained from ISEL studies to detect DNA fragmentation indicative of apoptosis. In control cultures incubated in 0.5% FCS
alone, <5% of the cells showed nuclear labeling, indicative of DNA
fragmentation. In contrast, in KICA-treated cultures the majority of
nuclei were stained positive by ISEL (Figure
4A). Similar morphological changes were
observed in the B104 and N1E-115 cell lines and with other BCKAs (our
unpublished results). In a separate series of experiments, we were also
able to detect the endonuclease-mediated degradation of chromatin,
giving rise to characteristic DNA laddering. C6 cells were incubated
for 0-48 h with KICA (50 mM), and total DNA was visualized at defined
time points by agarose gel electrophoresis. KICA induced DNA laddering in a time-dependent manner: cells at the beginning of the experiment contained only high-molecular-weight DNA, whereas at time points from
12 h onward, evidence of DNA fragmentation was present. From 18 h onward, low-molecular-weight DNA species could be detected that migrated as a ladder, with fragments differing by ~200 bp (Figure 4B). In a separate series of experiments, KICA was found to
induce DNA laddering in a dose-dependent manner, with maximal endonuclease activation occurring at the 50 mM (our unpublished results). Taken together, these data provide molecular evidence that
apoptotic proteases and endonucleases are activated in C6 cells after
KICA treatment.
|
KICA Triggers a Reduction in Cell Respiration
Because MSUD metabolites have been shown to inhibit mitochondrial
enzymes (Land et al., 1976
; Jackson and Singer, 1983
), we investigated the effect of KICA on cell respiration by polarography. As
shown in Table 1, after a 4-h exposure to
KICA or SSP, oxygen consumption by intact cells was impaired, although
mitochondrial succinate oxidation in permeabilized cells was comparable
with control values. Significantly, these parameters were not altered after the addition of exogenous cytochrome c (Figure
5B). At the same time point, however,
there was a 25% (KICA) and 50% (SSP) reduction in MTT metabolism
(Figure 5A), indicating that respiratory chain function was normal
despite the cells being in the irreversible phase of apoptosis.
|
|
KICA Induces Mitochondrial Death without Cytochrome c Release
A number of recent studies have established that cytochrome
c release from the mitochondria into the cytosol is a
frequent feature of the apoptotic program (Krippner et al.,
1996
; Kluck et al., 1997
; Yang et al., 1997
). We
therefore investigated the effect of KICA on the release of cytochrome
c into the cytosol of C6 cells. As shown in Figure 5C, both
cytochrome oxidase and cytochrome c were absent from the
cytosol of control cultures. Similarly, exposure of C6 cells to KICA
for up to 4 h resulted in a slight increase in cytochrome
c in the cytosolic fraction, although increased levels were
also observed in the mitochondrial fraction. In contrast, SSP-treated
cultures contained large amounts of cytochrome c in the
cytosol, and this was accompanied by a reduction in mitochondrial
cytochrome c levels. Cytochrome oxidase was only detected in
mitochondrial fractions in all samples tested and was unaltered after
exposure to KICA or SSP (Figure 5C). These data confirmed our
polarographic studies indicating that KICA induced impaired cellular
oxygen consumption without detectable cytochrome c involvement.
KICA Does Not Trigger Early Changes in Mitochondrial Membrane Potential
To investigate possible changes in 
m,
C6 cells were loaded with the cationic fluorochrome JC-1, the
aggregation of which depends on the 
m. In
control cultures, the ratio of JC-1 monomers to aggregates was <0.37,
reflecting the baseline for healthy mitochondria in C6 cells. After a
20-h treatment with SSP (1 µM) or valinomycin (1 µM), this figure
increased to 0.74 and 0.83, respectively, indicating significant
mitochondrial membrane depolarization. In contrast, a range of
concentrations of KICA up to 100 mM did not induce significant changes
in 
m (Figure
6A). To exclude the possibility that
early or transient changes in 
m were
missed, a time course study was carried out, measuring changes in JC-1 fluorescence between 1 and 20 h after the addition of KICA or control drugs. Valinomycin induced rapid changes in

m, detected as early as 10 min after
addition (our unpublished results) and sustained up to 20 h
(Figure 6B). SSP induced similar changes in mitochondrial membrane
potential, although the kinetics were slower; 3-4 h of treatment was
needed before changes in JC-1 disaggregation could be detected (our
unpublished results), whereas the effect was still present at the 20-h
time point. In contrast, KICA treatment did not result in mitochondrial
depolarization at any of the time points tested (Figure 6B), even
20 h after KICA treatment, although at this time point cells were
not viable (Figure 1). To investigate this apparent paradox further, we
expressed the fluorescence data from JC-1 monomers and aggregates
separately. As shown in Figure 6B, inset, fluorescence at both 530 and
590 nm was significantly reduced at 20 h. Thus although the ratio
of JC-1 monomers to aggregates was unaltered, the mitochondria were
clearly compromised in many cells at this time point.
|
The lack of effect of KICA on 
m was
confirmed at the single-cell level by fluorescence imaging. Healthy C6
cells loaded with JC-1 contained numerous intact mitochondria arranged
in a perinuclear manner. When excited at 490 nm, cells were highly fluorescent at an emission wavelength of 590 nm, indicating the presence of JC-1 aggregates. Within seconds of treatment with the
proton ionophore FCCP, a significant reduction in fluorescence was
observed that increased with time (our unpublished observations). In
contrast, no depolarization occurred at early time points after KICA
addition. At later time points only viable C6 cells contained polarized
mitochondria. These data indicate that KICA impaired mitochondrial
metabolism in C6 cells without affecting membrane potential at early
time points.
KICA Induces Apoptosis in Primary Neurons and Glia without Early
Changes in 
m
It was important to determine whether the toxic effects of KICA
could be reproduced in primary neurons. We therefore investigated the
effects of KICA on rat cerebellar granule cells (CGCs). Although control cultures contained predominantly healthy nuclei (Figure 7A), KICA-treated cells (Figure 7B)
underwent marked nuclear pyknosis, comparable with those treated with
SSP (Figure 7C). Quantitative analysis indicated that KICA induced
apoptosis in CGCs in a dose-dependent manner, with 50% death observed
at KICA concentrations between 1 and 10 mM (Figure
8A). Because MSUD is primarily a white
matter disease, we also investigated the toxic effects of KICA on
primary rat oligodendrocytes and astrocytes. As in the case of CGCs,
KICA induced cell death in oligodendrocytes and astrocytes in a
dose-dependent manner. At lower concentrations (1 mM) both glial cell
types were more sensitive to KICA than neurons, with oligodendrocytes
(Figure 8B) slightly more sensitive than astrocytes (Figure 8C). The
dead cells displayed classic morphological features of apoptosis,
including cytoplasmic shrinkage and nuclear pyknosis, and were
indistinguishable from those exposed to SSP (our unpublished results).
|
|
We next investigated the effect of KICA and SSP on

m using three separate mitochondrial
potential indicator dyes, JC-1, TMRE, and Rh-123. At early time points
in SSP-treated CGC cultures, the fluorescence of JC-1 aggregates
(Figure 7F) was diminished, and the dye had dispersed into the
cytoplasm, indicating marked depolarization. In contrast, at comparable
times in KICA-treated cells (Figure 7E), JC-I fluorescence was
comparable with controls (Figure 7D): bright, punctate staining, which
was colocalized to mitochondria. At later time points, the number of
viable CGCs was reduced, although those remaining retained mitochondria
in the polarized state. These data were confirmed using the
rhodamine-based dyes Rh-123 and TMRE (our unpublished data).
Mitochondrial membrane potential was also investigated in primary CGCs
using the rhodamine-based dyes TMRE and Rh-123. Solvent addition or
KICA treatment did not cause a significant reduction in either TMRE
(Figure 9A) or Rh-123 (Figure 9B)
fluorescence. In contrast, the addition of the uncoupler FCCP (after
KICA) immediately depolarized mitochondria by up to 35% (Figure 9). In
both TMRE- and Rh-123-loaded cells, KICA did cause a slight reduction
in fluorescence at later time points, although these cells still responded equally well to FCCP. After prolonged periods of loading, both TMRE and Rh-123 fluorescence was significantly reduced, even in
control cultures. Microscopic examination of the cultures indicated that TMRE was toxic to primary CGC' (our unpublished data). These data
confirmed our findings with JC-1, indicating that early changes in

m did not precede caspase activation in
KICA-treated cells.
|
Intracerebral Injection of KICA Induces Neuronal Apoptosis In Vivo
Taken together, these results suggested that the neural impairment
observed in MSUD patients was a direct consequence of KICA neurotoxicity. To test the ability of KICA to induce apoptosis in vivo,
we injected defined concentrations ranging from 0 to 200 mM (corrected
for osmolarity and pH 7.40) into the hippocampus of 14-d-old rats and
investigated apoptosis by ISEL at 24 h and 5 d after
injection. Injection of 0.9% NaCl had no detectable effect on cell
survival after 24 h or 5 d (Figure
10A). In contrast, after intracerebral
injection of KICA, cell apoptosis could be detected by ISEL in the area
surrounding the injection site, encompassing the CA1 region and the
dentate gyrus of the hippocampus. The number of apoptotic cells in this
region increased with the concentration of KICA, with a maximal effect
observed 5 d after injection of 200 mM KICA (Figure 10, B and C).
When viewed under higher magnification, the majority of apoptotic cells
were pyramidal neurons and granule cells (Figure 10C). These results
indicated that KICA also triggered cell apoptosis in vivo in a
dose-dependent manner.
|
| |
DISCUSSION |
|---|
|
|
|---|
Toxic effects of the metabolites that accumulate in MSUD have been
previously demonstrated in the rat cerebellum, where myelination was
severely impaired (Silberberg, 1969
), and in lymphoblastoid cell lines
from MSUD patients, where significant growth inhibition was observed
(Skaper et al., 1976
). In earlier studies the effects on C6
cells were interpreted as an increase in cell cycle time; morphological
changes indicative of apoptosis were present but not commented on (Liao
et al., 1978
). In the present study, we demonstrate that the
toxic effects of MSUD metabolites are due to the induction of apoptotic
cell death, verified by classical morphological criteria, ISEL of
apoptotic nuclei, evidence of caspase activation and nucleosome laddering.
It should noted that caspase 3 activity was only moderately increased
after exposure to KICA compared with SSP. Moreover, the observation
that neither IETD-FMK nor DEVD-FMK prevented the decrease in MTT
reduction suggests that neither activation of caspase 8 nor that of
caspase 3 is a major component of the KICA apoptosis pathway. This is
consistent with a growing number of separate studies (Miller et
al., 1997
; Ha et al., 1998
; Monney et al.,
1998
; Drenou et al., 1999
; Mateo et al., 1999
;
Jones et al., 2000
) indicating that apoptosis can proceed
through caspase-independent pathways. On the other hand, the protective
effects of BAF and the characteristic cleavage of PARP indicate that
other caspases may be activated in KICA-induced apoptosis.
All three BCKAs tested induced significant reductions in glial and
neuronal cell viability. These results are consistent with those of
Bissel et al. (1974)
, who observed that the replication of
mouse fibroblasts was inhibited by all three BCKAs (KICA,
-keto valeric acid, and KILE), Zielke et al. (1997)
, who
recently reported that KICA reduced energy metabolism in rat brain, and
Patel (1974)
, who found that all three BCKAs inhibited the
mitochondrial BCKA dehydrogenase complex in the developing rat brain.
In contrast, Silberberg (1969)
did not observe any toxic effects of
-keto valeric acid on myelinating cultures of rat cerebellum. One
explanation might be that these cells are known to metabolize BCAAs
quickly. Alternatively, cerebellar cultures may be resistant to the
effects of BCAAs but succumb to combinations of the BCAA with the
corresponding keto acid. The data presented here emphasize the
importance of this synergy: leucine at high concentrations is only
slightly toxic but at lower concentrations acts synergistically with
BCKA to trigger apoptosis. This effect may be particularly important in
the brain where high aminotransferase activity rapidly metabolizes leucine to KICA (Brand et al., 1984
). We found that the two
other BCKAs that accumulate in MSUD are also toxic to C6 cells and may therefore contribute to neurological damage in MSUD patients, although
their concentration in plasma is relatively low (Snyderman et
al., 1984
).
Previous studies suggested that KICA disrupts energy metabolism by
inhibiting the mitochondrial pyruvate and
-ketoglutarate dehydrogenases (Dreyfus and Prensky, 1967
; Walajtys-Rode and
Williamson, 1980
; Jackson and Singer, 1983
) and the pyruvate and
-hydroxybutyrate translocases (Land et al., 1976
).
Moreover, it has become apparent that apoptotic execution can involve
the release of mitochondrial cytochrome c into the cytosol
(Kluck et al., 1997
; Yang et al., 1997
). The
resulting impairment of mitochondrial function can be largely corrected
by the addition of exogenous cytochrome c (Krippner et
al., 1996
).
Because mitochondrial changes at the ultrastructural level in
KICA-treated cells are consistent with apoptosis, it is not clear
whether these changes reflect the cause or are a consequence of
apoptosis. We therefore investigated whether KICA triggers apoptosis
through a mechanism impinging on cell oxidative metabolism and the
release of cytochrome c. In particular we measured intact cell respiration and the rate of mitochondrial succinate oxidation in
permeabilized cells (reflecting the function of respiratory chain
complexes II, III, and IV of the ubiquinone pool and of cytochrome
c). Our results indicate that cell respiration is
significantly decreased by KICA, and this parallels an irreversible
commitment to apoptotic death in C6 cells. In contrast, KICA does not
affect the succinate oxidation rate, suggesting that the respiratory chain is essentially unaffected after exposure to MSUD metabolites; in
particular, mitochondrial cytochrome c levels do not become limiting. This was confirmed by immunoblotting studies
and by the inability of exogenous cytochrome c to correct
the succinate oxidation rate. Similar observations have been made in
murine T lymphocytes (Hockenbery et al., 1993
). These data
suggest that apoptotic execution can proceed without significant loss
of cytochrome c and without changes in

m and agree with recent studies in lymphoid
cell lines (Tang et al., 1998
), Hela cells (Bossy-Wetzel et al., 1998
), myeloid cells (Finucane et al.,
1999
), and primary cerebellar granule neurons (Paterson et
al., 1998
).
Our immunoblotting data are in accord with a number of
recent reports that mitochondrial release of cytochrome c is
not an obligatory event for apoptotic cell death but is dependent on the apoptotic trigger in a range of cell types (Adachi et
al., 1997
; Chauhan et al., 1997
; Li et al.,
1997
; Tang et al., 1998
). Indeed, we and others (Tang
et al., 1998
) have observed an increase in mitochondrial
cytochrome c levels without any increase in the cytosol. So,
although cell respiration is impaired after exposure to MSUD
metabolites, it is not clear whether this is the trigger or a
consequence of apoptotic cell death. The absence of significant early
changes in mitochondrial cytochrome c or

m, are consistent with the latter possibility.
Our data using three separate dyes to measure

m conclusively show that KICA does not
induce early mitochondrial depolarization. This observation is in
accord with recent studies challenging the assertion that a reduction
in 
m is a ubiquitous event in the apoptotic
program (Garland et al., 1997
; Finucane et al., 1999
). It is worthy of note that in our hands all three dyes used to
measure 
m showed inadequacies at prolonged
time points: JC-1 fluorescence ratios remained constant after a 20-h
exposure to KICA, although the mitochondria were metabolically dead. On
closer examination, fluorescence of both JC-1 monomers and
J-aggregates, probably because of severely damaged mitochondria, was
equally unable to retain the dye. Using Rh-123 or TMRE,
potential-dependent staining of mitochondria can also be obtained, with
membrane potential measurements largely following the Nernst equation.
In this study, Rh-123-loaded CGCs showed reduced fluorescence at late
time points, probably because of self-quenching (Bindokas et
al., 1998
), and TMRE, which has been shown to inhibit cell
respiration (Scaduto and Grotyohann, 1999
), was toxic after prolonged
treatment of CGCs.
Our results provide useful information for patient management; plasma
leucine levels are routinely used to monitor the treatment of MSUD, and
circulating concentrations of BCAAs are a good indicator of the risk of
neurological injury (Riviello et al., 1991
). On the other
hand, our results indicate that keto acids are more toxic than their
parent amino acids and suggest that it would be more beneficial to
patients if circulating BCKAs were reduced rather than the parent BCAAs.
The present study also showed that direct intracerebral injection of KICA leads to neuronal apoptosis in the hippocampus of neonatal rats in a dose-dependent manner. To our knowledge, this is the first demonstration of the neurotoxic effect of BCKAs and, if confirmed in brain specimens from MSUD patients, will have important implications for the design of therapeutic strategies to prevent or limit cerebral injury that occurs during the acute-onset MSUD. Our observations in vivo also suggest, rather provocatively, that other conditions associated with keto acid accumulation (e.g., diabetic acidosis) may also have an apoptotic component in the neurological deficit.
In summary, we have demonstrated that the branched chain amino and keto acids that accumulate in MSUD trigger apoptosis in glial and neuronal cells in vitro and in vivo in a dose- and time-dependent manner. These observations may explain, at least in part, the neurological sequelae associated with high plasma concentrations of MSUD metabolites.
| |
ACKNOWLEDGMENTS |
|---|
We thank the Weston Foundation for continued financial support (to M.K., A.D.E., and H.M.). D.L.T. is funded by Wellcome Trust grant 046343/z/95; U.J. is an Action Research clinical research fellow; and K.G. is supported by Sir Jules Thorn Charitable Trust grant 96/76A.
| |
FOOTNOTES |
|---|
§ Present address: Oxford BioMedica, Medawar Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford OX4 4GA, United Kingdom.
¶ Corresponding author. E-mail address: h.mehmet{at}ic.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
-keto acid metabolism. In: Branched Chain Amino and Keto Acids in Health and Disease, Vol. 1, ed. S.A. Adibi,
W. Fekl,
U. Langenbeck, and
P. Schauder, Basel: Karger, 100-111.
-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease.
J.Neurochem.
26, 823-830[Medline].